TC
BIIB icon

TownSquare Capital’s Biogen BIIB Stock Holding History

TownSquare Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,985
Closed -$408K – 697
2025
Q1 		$408K Buy
2,985
+174
+6% +$24.9K ﹤0.01% 1217
2024
Q4 		$430K Sell
2,811
-9,997
-78% -$1.69M ﹤0.01% 1094
2024
Q3 		$2.48M Sell
12,808
-941
-7% -$197K 0.03% 492
2024
Q2 		$3.19M Sell
13,749
-88
-0.6% -$19.1K 0.04% 374
2024
Q1 		$2.98M Sell
13,837
-1,689
-11% -$396K 0.04% 359
2023
Q4 		$4.02M Sell
15,526
-761
-5% -$187K 0.07% 271
2023
Q3 		$4.19M Sell
16,287
-568
-3% -$152K 0.08% 242
2023
Q2 		$4.8M Buy
16,855
+1,682
+11% +$501K 0.09% 216
2023
Q1 		$4.22M Buy
15,173
+90
+0.6% +$24.9K 0.09% 203
2022
Q4 		$4.18M Buy
15,083
+1,825
+14% +$515K 0.1% 187
2022
Q3 		$3.54M Buy
13,258
+691
+5% +$147K 0.1% 178
2022
Q2 		$2.56M Buy
12,567
+589
+5% +$120K 0.07% 224
2022
Q1 		$2.52M Buy
11,978
+2,894
+32% +$629K 0.06% 243
2021
Q4 		$2.18M Sell
9,084
-455
-5% -$117K 0.05% 265
2021
Q3 		$2.7M Buy
9,539
+1,161
+14% +$381K 0.08% 216
2021
Q2 		$2.89M Buy
8,378
+1,335
+19% +$404K 0.09% 190
2021
Q1 		$1.97M Buy
7,043
+1,521
+28% +$410K 0.08% 210
2020
Q4 		$1.35M Sell
5,522
-113
-2% -$29.2K 0.06% 240
2020
Q3 		$1.58M Buy
5,635
+1,050
+23% +$293K 0.09% 172
2020
Q2 		$1.27M Buy
4,585
+935
+26% +$281K 0.09% 171
2020
Q1 		$1.07M Buy
3,650
+1,445
+66% +$439K 0.09% 169
2019
Q4 		$654K Buy
2,205
+244
+12% +$67.7K 0.05% 240
2019
Q3 		$563K Buy
1,961
+1,062
+118% +$247K 0.05% 286
2019
Q2 		$218K Buy
+899
New +$208K 0.02% 428

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TownSquare Capital's BIIB Position: Q2 2025 in Review

TownSquare Capital sold out of Biogen (BIIB) in Q2 2025, closing a stake of 2,985 shares — an estimated $408K sold.

TownSquare Capital first reported a position in BIIB in Q2 2019 and held it in 24 quarters. The position peaked at $4.8M in Q2 2023. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • TownSquare Capital reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 2,985 Biogen shares in Q2 2025, an estimated $408K.
  • TownSquare Capital first reported a position in Biogen in Q2 2019 and held it in 24 quarters.
  • TownSquare Capital's Biogen position peaked at $4.8M in Q2 2023.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.